2021-07-24-accounts

Trustees’ Annual Report for the period

From 25/7/2020 Period start date To 24/7/2021 Period end date

Charity name: ASSOCIATION FOR THE GLOBAL ADVANCEMENT OF ENT SURGERY AND HEAD AND NECK CANCER RESEARCH

Charity registration number: 1165453

Objectives and Activities

	SORP reference
Summary of the purposes of the charity as set out in its governing document	Para 1.17	The advancement of health and relief of sickness in the field of ear, nose and throat/head and neck surgery and head and neck disorders across the world in particular but not exclusively by: · Supporting the provision of awareness and screening programmes · Supporting cancer research by the provision of grants (AGA-ENT Charity Governing document - version 1.1-21/1/2016)
Summary of the main activities in relation to those purposes for the public benefit, in particular, the activities, projects or services identified in the accounts.	Para 1.17 and 1.19	· Supporting the provision of awareness and screening programmes · Supporting cancer research by the provision of grants
Statement confirming whether the trustees have had regard to the guidance issued by the Charity Commission on public benefit	Para 1.18	Yes, the trustees have had regard.

Additional information (optional)

You may choose to include further statements where relevant about:

SORP reference N/A Para 1.38 Policy on grant making N/A Para 1.38 Policy on social investment including program related investment

Contribution made by volunteers	Para 1.38	Minor contributions, e.g. help with website.
Other		N/A

Achievements and Performance

	SORP reference
Summary of the main achievements of the charity, identifying the difference the charity’s work has made to the circumstances of its beneficiaries and any wider benefits to society as a whole.	Para 1.20	Our work has unfortunately been affected by the pandemic, but we have aimed to continue the fundraising in order to get the programme established fully in 2022/2023 again After our BICRAA app (www.bicraa.org) had been successfully tested in India (n=1049), showing that around 30% chew betel nut (we would like to thank Prof. Kelkar and Dr. Pethe from the Deenanath Mangeshkar Hospital, Pune, for their invaluable support), the app has continued to help raise the awareness of the risks of betel nut chewing. We have continued working on a global study to extend these efforts in India and other countries. With regard to our work in Indonesia, we have continued to closely work with our partners at the Dr. Sardjito Hospital/Gadjah Mada University in Yogyakarta, Indonesia, and affiliated district general hospitals in collaboration with Prof. Bing Tan to support the local Nasopharyngeal Cancer (NPC) awareness and early detection programme and to support research and publications of results. The Storz company has continued to support our programme and in 2019 we were able to award four fellowship grants to young surgeons, sponsored by a donation by Storz, allowing them travel to low and middle income countries and to helpi with the local charitable work. In 2020 we awarded two more fellowships and these have unfortunately been delayed by the pandemic, but will be completed in 2022/2023.

Additional information (optional) You may choose to include further statements	Additional information (optional) You may choose to include further statements	where relevant about:
	Para 1.41	As above. Taking the above work into account AGA-ENT has made contributions to the advancement of health and relief of

Achievements against objectives set		sickness in the field of ear, nose and throat/head and neck surgery and head and neck disorders in low and middle income countries. However, our work has unfortunately been affected by the pandemic, but we have aimed to continue the fundraising in order to get the programme established fully in 2022/2023 again.
Performance of fundraising activities against objectives set	Para 1.41	Good progress. Substantive funding will be sought once the preliminary data are published.
Investment performance against objectives	Para 1.41	N/A
Other		N/A

Financial Review

Financial Review
Review of the charity’s financial position at the end of the period	Para 1.21	24/7/2021
Statement explaining the policy for holding reserves stating why they are held	Para 1.22	Year on year the charity hopes to increase the reserves to be in line with 2 years possible commitments
Amount of reserves held	Para 1.22	£1000
Reasons for holding zero reserves	Para 1.22	N/A
Details of fund materially in deficit	Para 1.24	N/A
Explanation of any uncertainties about the charity continuing as a going concern	Para 1.23	N/A

Additional information (optional) You may choose to include further statements where relevant about:

The charity’s principal sources of funds (including any fundraising)	Para 1.47	Donations by private donors and donated equipment.
Investment policy and objectives including any social investment policy adopted	Para 1.46	N/A
A description of the principal risks facing the charity	Para 1.46	At present funds are sufficient to achieve the aims set, but more funding needs to be sought to continue to expand our work. Ensuring the ongoing income is the most important risk we manage.
Other		N/A

Structure, Governance and Management

Description of charity’s trusts:
Type of governing document (trust deed, royal charter)	Para 1.25	Constitution of the Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research (AGA- ENT), a Charitable Incorporated Organisation with voting members other than its charity trustees Date of constitution (last amended): 21/01/2016 (AGA-ENT Charity Governing document - version 1.1 - 21/1/2016)
How is the charity constituted? (e.g unincorporated association, CIO)	Para 1.25	Charitable Incorporated Organisation
Trustee selection methods including details of any constitutional provisions e.g. election to post or name of any person or body entitled to appoint one or more trustees	Para 1.25	The current trustees volunteered to take on these roles with the support of all founding members and fulfil these roles in line with the duties outlined in the AGA-ENT Charity Governing document - version 1.1 - 21/1/2016

Additional information (optional) You may choose to include further statements where relevant about:

Policies and procedures adopted for the induction and training of trustees	Para 1.51	All duties outlined in the AGA-ENT Charity Governing document - version 1.1 - 21/1/2016 and discussed during regular Trustees’ meetings.
The charity’s organisational structure and any wider network with which the charity works	Para 1.51	Charitable Incorporated Organisation with voting members other than its charity trustees
Relationship with any related parties	Para 1.51	Collaborators and partners globally who help to achieve the outlined objectives, usually within the network of Founding Members.
Other		N/A

Reference and Administrative details

Charity name Association for the Global Advancement of ENT Surgery and - Head and Neck Cancer Research (AGA ENT) Other name the charity uses AGA-ENT Registered charity number 1165453

Charity’s principal address Association for the Global Advancement of ENT Surgery and Head and Neck Cancer Research (AGA-ENT), Beacon House, 113 Kingsway, London, WC2B 6PP

Names of the charity trustees who manage the charity

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20	Trustee name	Office (if any)	Dates acted if not for whole **year **	Name of person (or body) entitled to appoint trustee (ifany)
	Paul O’Flynn		5/2/2016 – current date	Membershipbody
	Matt Lechner		5/2/2016 – current date	Membershipbody
	Valerie J. Lund		5/2/2016 – current date	Membershipbody
	Francis M. Vaz		5/2/2016 – current date	Membershipbody
	Tim Tang		5/2/2016 - 4/6/2017	Membershipbody

– Corporate trustees names of the directors at the date the report was approved

Director name N/A

Name of trustees holding title to property belonging to the charity

Trustee name	Dates acted if not for whole year
N/A

Funds held as custodian trustees on behalf of others

Description of the assets None held in this capacity Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets

Additional information (optional)

Names and addresses of advisers (Optional information)

Names and addresses of advisers (Optional information)	Names and addresses of advisers (Optional information)	Names and addresses of advisers (Optional information)
Type of adviser Name Address
N/A
Name of chief executive or names of senior staff members (Optional information)
N/A

Exemptions from disclosure

Reason for non-disclosure of key personnel details

The charity is too small still to employ personnel

Other optional information

N/A

Declarations

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s) Full name(s) Position (eg Secretary, Chair, etc) Date
	Matt Lechner	Valerie J. Lund
	Trustee
	19/05/2022
	19/05/2022

Receipts and payments accounts CC16a For the per￿$ To Section A Receipts and payments Unrestricted funds Endowment funds Total funds La51 ￿ar tothemtaregt£ A1 Recei rk>nAtion5 Fd10￿1p FundirJ 8.500 3,192 3.192 Sub total(Gmss for 12.600 AR) A2 Asset aEKI investment sales. see table . tot 6.792 6,792 12,500 A3Pa ents Fwdtsising costs Web h05ts Fe1bw￿ljP ￿rdS Research costs 121 121 421 634 4,000 5,000 PDDtiry. ￿stage and stabonory ce costs 132 960 Sundry exp8fLses 137 BÈnk charges 41 Sub total 11.584 A4 Asset and fin￿lment urchase5 s& table Sub total TotaIpa￿nents 11,584 Net of r8ceiptsl(paTrrynents) AS Transters llwetn funds Cash funds last year end Cash funds Ihis year end 916 4.128 10,576 4,128 10,576 3,212 4,120

Section B Statement of assets and liabilities at the end of the period UnTestricted funds Restricted funds Endowwnent funds to neares1£ to nea￿&t É 81 Cash funds 10.576 Tolal ca4R fun¢ts 10,576 xxwd(s)} Unrestrthd fund5 to I¥￿st £ Endowment funds funds to nearest £ Delails to neaies¢£ Current value l¢Jptional Detalls ¥s#et t C05t (op￿onall B3 Investment assets FI￿d to thich Gurrent value ional Detalls Cost lotthn￿l B4 Assets retained forlhe harity's use F￿￿1o￿￿1ch "at"lity rels w￿￿￿ loptKnall Details BS Liabilities Siyned by one or truBtees on beham of all the tru5tee5 Sigmature Pn"nt Name- Date of roval Ni. M4rr LiCHfvJt 2¥16/2&1